Back
Plus Therapeutics Vs. Citius Pharmaceuticals Industry Stock Comparison
Buy
57
PSTV
Plus Therapeutics
Last Price:
2.43
Seasonality Move:
-7.08%
Sell
34
CTXR
Citius Pharmaceuticals
Last Price:
0.67
Seasonality Move:
-1.23%
Buy
57
Plus Therapeutics (PSTV)
is a Buy
Is Plus Therapeutics a Buy, Sell or Hold?
- The current Plus Therapeutics [PSTV] share price is $2.13. The Score for PSTV is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
- PSTV is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
34
Citius Pharmaceuticals (CTXR)
is a Sell
Is Citius Pharmaceuticals a Buy, Sell or Hold?
- The current Citius Pharmaceuticals [CTXR] share price is $0.69. The Score for CTXR is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
- CTXR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PSTV Stock Price Chart
What is Plus Therapeutics's stock price today?
-
The Plus Therapeutics share price today is $2.13
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PSTV is experiencing buying pressure, which is a positive indicator for future bullish movement.
CTXR Stock Price Chart
What is Citius Pharmaceuticals's stock price today?
-
The Citius Pharmaceuticals share price today is $0.69
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CTXR is experiencing slight buying pressure.
PSTV Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.03 | Buy |
| Relative Strength Index (14 RSI): | 71.02 | Buy |
| Chaikin Money Flow: | 85977 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.66 - 1.92) | Buy |
| Bollinger Bands (100): | (1.74 - 2.04) | Buy |
CTXR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.03 | Sell |
| Relative Strength Index (14 RSI): | 41.19 | Sell |
| Chaikin Money Flow: | 590441 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.69 - 0.89) | Sell |
| Bollinger Bands (100): | (0.68 - 0.84) | Sell |
PSTV Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.82 | Buy |
| 20-day SMA: | 1.76 | Buy |
| 50-day SMA: | 1.82 | Buy |
| 200-day SMA: | 1.86 | Buy |
| 8-day EMA: | 1.87 | Buy |
| 20-day EMA: | 1.81 | Buy |
| 50-day EMA: | 1.82 | Buy |
| 200-day EMA: | 2.32 | Sell |
CTXR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.7 | Sell |
| 20-day SMA: | 0.75 | Sell |
| 50-day SMA: | 0.78 | Sell |
| 200-day SMA: | 0.79 | Sell |
| 8-day EMA: | 0.71 | Sell |
| 20-day EMA: | 0.74 | Sell |
| 50-day EMA: | 0.77 | Sell |
| 200-day EMA: | 0.83 | Sell |
Plus Therapeutics Earnings Growth & PSTV Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.49 per share, a decrease next quarter of $0.04 per share, an increase this year of $2.58 per share, and an increase next year of $0.41 per share.
Citius Pharmaceuticals Earnings Growth & CTXR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and an increase next year of $0.30 per share.
Plus Therapeutics Technical Analysis
| Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Citius Pharmaceuticals Technical Analysis
| Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||